|Offre||141,66 x 0|
|Vente||142,66 x 0|
|Var. jour||140,50 - 141,88|
|Sur 52 semaines||111,80 - 153,55|
|Bêta (mensuel sur 5 ans)||S.O.|
|Rapport P/E (sur 12 mois)||S.O.|
|BPA (sur 12 mois)||S.O.|
|Date de bénéfices||01 févr. 2023 - 06 févr. 2023|
|Dividende et rendement à terme||S.O. (S.O.)|
|Objectif sur 1 an||S.O.|
NORTHAMPTON, MA / ACCESSWIRE / November 8, 2022 / Quest Diagnostics Healthy NewsWorks Healthy NewsWorks (HNW) empowers elementary and middle-school students to advocate for health literacy through school-based journalism programs. HNW provides ...
Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced that Jim Davis has succeeded Steve Rusckowski as the CEO and President of Quest Diagnostics, completing a transition first announced on February 3, 2022.
According to the Association of American Medical Colleges, only 8% of medical students and 5% of physicians are Black and African American.